Previous Article in Journal
Oncological Complications of Liver Transplantation: A Narrative Review on De Novo and Donor-Transmitted Cancers
 
 
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Correction

Correction: Whitrock et al. Novel Study of SARS-CoV-2 RNA in Post-Reperfusion Liver Biopsies after Transplantation Using COVID-19-Positive Donor Allografts. Transplantology 2024, 5, 46–50

1
Cincinnati Research in Outcomes and Safety in Surgery (CROSS) Research Group, Department of Surgery, University of Cincinnati College of Medicine, Cincinnati, OH 45267, USA
2
Department of Pathology, University of Cincinnati College of Medicine, Cincinnati, OH 45267, USA
3
Division of Transplantation, Department of Surgery, University of Cincinnati College of Medicine, Cincinnati, OH 45267, USA
*
Author to whom correspondence should be addressed.
Transplantology 2025, 6(2), 16; https://doi.org/10.3390/transplantology6020016
Submission received: 24 April 2025 / Accepted: 13 May 2025 / Published: 19 May 2025
In the original publication [1], the Informed Consent Statement was incorrectly listed as “Not applicable.” The correct Informed Consent Statement appears below.
  • Informed Consent Statement: Informed consent for participation was not required due to the retrospective nature of the study, as approved by the Institutional Review Board of the University of Cincinnati College of Medicine.
The authors state that the Institutional Review Board has waived the requirement to obtain informed consent for participants and the scientific conclusions are unaffected. This correction was approved by the Academic Editor. The original publication has also been updated.

Reference

  1. Whitrock, J.N.; Carter, M.M.; Price, A.D.; Delman, A.M.; Pratt, C.G.; Wang, J.; Sharma, D.; Quillin, R.C., III; Shah, S.A. Novel Study of SARS-CoV-2 RNA in Post-Reperfusion Liver Biopsies after Transplantation Using COVID-19-Positive Donor Allografts. Transplantology 2024, 5, 46–50. [Google Scholar] [CrossRef]
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content.

Share and Cite

MDPI and ACS Style

Whitrock, J.N.; Carter, M.M.; Price, A.D.; Delman, A.M.; Pratt, C.G.; Wang, J.; Sharma, D.; Quillin, R.C., III; Shah, S.A. Correction: Whitrock et al. Novel Study of SARS-CoV-2 RNA in Post-Reperfusion Liver Biopsies after Transplantation Using COVID-19-Positive Donor Allografts. Transplantology 2024, 5, 46–50. Transplantology 2025, 6, 16. https://doi.org/10.3390/transplantology6020016

AMA Style

Whitrock JN, Carter MM, Price AD, Delman AM, Pratt CG, Wang J, Sharma D, Quillin RC III, Shah SA. Correction: Whitrock et al. Novel Study of SARS-CoV-2 RNA in Post-Reperfusion Liver Biopsies after Transplantation Using COVID-19-Positive Donor Allografts. Transplantology 2024, 5, 46–50. Transplantology. 2025; 6(2):16. https://doi.org/10.3390/transplantology6020016

Chicago/Turabian Style

Whitrock, Jenna N., Michela M. Carter, Adam D. Price, Aaron M. Delman, Catherine G. Pratt, Jiang Wang, Divya Sharma, Ralph C. Quillin, III, and Shimul A. Shah. 2025. "Correction: Whitrock et al. Novel Study of SARS-CoV-2 RNA in Post-Reperfusion Liver Biopsies after Transplantation Using COVID-19-Positive Donor Allografts. Transplantology 2024, 5, 46–50" Transplantology 6, no. 2: 16. https://doi.org/10.3390/transplantology6020016

APA Style

Whitrock, J. N., Carter, M. M., Price, A. D., Delman, A. M., Pratt, C. G., Wang, J., Sharma, D., Quillin, R. C., III, & Shah, S. A. (2025). Correction: Whitrock et al. Novel Study of SARS-CoV-2 RNA in Post-Reperfusion Liver Biopsies after Transplantation Using COVID-19-Positive Donor Allografts. Transplantology 2024, 5, 46–50. Transplantology, 6(2), 16. https://doi.org/10.3390/transplantology6020016

Article Metrics

Back to TopTop